Dyne Therapeutics Receives FDA Breakthrough Therapy Designation for DM1 Drug DYNE-101
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the best biotech stocks to invest in now.
Dyne Therapeutics Inc. (DYN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 9,714,392 | $101,612,540 | +53% | 1.7% |
| 2. | Braidwell LP Alex Karnal | 3,621,344 | $37,879,258 | +432% | 1.33% |
| 3. | Citadel Investment Group Ken Griffin | 3,009,389 | $31,478,209 | +6% | 0.01% |
| 4. | Armistice Capital Steven Boyd | 2,768,000 | $28,953,280 | +187% | 0.43% |
| 5. | Siren L.L.C. Raymond Debbane | 2,717,987 | $28,430,144 | +102% | 1.6% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.09 | 7,200 | $238,248.00 | 8,000 | 2024-09-04 | Filing | |
| $32.57 | 800 | $26,056.00 | 800 | 2024-09-04 | Filing | |
| $33.09 | 7,200 | $238,248.00 | 8,000 | 2024-09-04 | Filing | |
| $32.57 | 800 | $26,056.00 | 800 | 2024-09-04 | Filing | |
| $33.09 | 7,200 | $238,248.00 | 8,000 | 2024-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.35 | 4,060 | $54,201.00 | 142,179 | 2025-06-05 | Filing | |
| $13.35 | 1,342 | $17,915.70 | 92,815 | 2025-06-05 | Filing | |
| $13.35 | 146 | $1,949.10 | 95,911 | 2025-06-05 | Filing | |
| $12.12 | 143 | $1,733.16 | 96,057 | 2025-03-13 | Filing | |
| $11.38 | 1,343 | $15,283.34 | 122,330 | 2025-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,353,416 | $118,465,941 | 0.06% | |
| 2. | 9,130,465 | $95,504,664 | 18.3% | |
| 3. | 8,046,938 | $84,170,972 | 0% | |
| 4. | 7,406,344 | $77,470,358 | 0% | |
| 5. | 5,462,846 | $57,141,369 | 13.81% |
News See All
13 Best Biotech Stocks To Invest In Now
In 2023, the global biotechnology market size was estimated at $1.55 trillion.
11 Most Promising Small-Cap Stocks According to Analysts
Robert Teeter of Silvercrest Asset Management recently appeared in an interview to express that he thinks small-cap stocks are currently facing a choppy market, but he also acknowledged that he anticipates...
10 Best Rebound Stocks To Invest In Now
The United States economy is in a constant state of flux.
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts
Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.
10 Best Hot Stocks To Buy Right Now
While the market is seeing significant positives after the Fed rate cut, there have been some pressures.
14 Stocks With Heavy Insider Buying In 2024
Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months to come.
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
Hedge Fund and Insider Trading News: Blackwells Capital, AQR Capital Management, Vivid Capital Management, Carparts.com Inc (PRTS), Dyne Therapeutics, Inc. (DYN), and More
Blackwells Capital, a hedge fund seeking to replace some of the board directors at Global Net Lease Inc and Necessity Retail REIT Inc, told Reuters on Monday it has filed a lawsuit against the real estate...
Billionaire Hedge Funds
